• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Novel approaches with ifosfamide in small cell lung cancer.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Thatcher, Nick
    Lind, Michael J
    De Campos, E S
    Cerny, T
    Affiliation
    Cancer Research Campaign Department of Medical Oncology, Christie Hospital, Manchester, UK.
    Issue Date
    1992-02
    
    Metadata
    Show full item record
    Abstract
    During the past 5 years, ifosfamide has been used increasingly in combination chemotherapy for small cell lung cancer (SCLC). The high activity and favorable toxicity spectrum (with the uroprotector mesna) will encourage further use. A policy of no dosage reduction is feasible in patients receiving combination chemotherapy with ifosfamide given as a 24-hour intravenous (IV) infusion, which is much more convenient than the more commonly used 4- to 5-day fractionated regimen. This policy has resulted in actual 2-year survivals of 22% to 33% among SCLC patients not intensively staged. The stability of ifosfamide and its high bioavailability have allowed its use in chronic, 7-day ambulatory IV infusions, with decreased toxicity and hospitalization. Recently, oral and subcutaneous administration also have been tried, again allowing outpatient treatment. The first studies with hemopoietic growth factor support, eg, granulocyte colony-stimulating factor, conducted with combination chemotherapy with ifosfamide-containing regimens in SCLC, demonstrated significant reduction in neutropenia, infections, and antibiotic use. It is clear that the dosage of ifosfamide can be intensified in the future. The broad versatility of the drug will allow interesting new studies, including those to be conducted with outpatients.
    Citation
    Novel approaches with ifosfamide in small cell lung cancer. 1992, 19 (1 Suppl 1):68-77 Semin Oncol
    Journal
    Seminars in Oncology
    URI
    http://hdl.handle.net/10541/107508
    PubMed ID
    1329215
    Type
    Article
    Language
    en
    ISSN
    0093-7754
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    • Authors: Chen YM, Liu JM, Wu MF, Wu HW, Lin WC, Tsai CM, Perng RP, Whang-Peng J
    • Issue date: 1998 Jul
    • Overview of ifosfamide in small cell lung cancer.
    • Authors: Ettinger DS
    • Issue date: 1992 Feb
    • Overview of ifosfamide in small cell and non-small cell lung cancer.
    • Authors: Johnson DH
    • Issue date: 1990 Apr
    • Phase II study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer.
    • Authors: Thongprasert S
    • Issue date: 2000 May
    • Ifosfamide in small cell lung cancer.
    • Authors: Einhorn LH
    • Issue date: 1989 Feb
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.